School of Medicine
Showing 1-10 of 111 Results
-
Kari Nadeau, MD, PhD
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Pediatrics, Senior Fellow at the Woods Institute and Professor, by courtesy, of Otolaryngology and of Epidemiology and Population Health at LPCH
Current Research and Scholarly Interests Kari Nadeau, MD, PhD, Allergy, Immunology and Asthma
Our research interests in the laboratory focus on the role of human T cells, specifically natural regulatory T cells (Treg, in immunological diseases. We aim to differentiate the mechanisms of action of regulatory T cell suppressive function. We study how pollution, such as diesel exhause, disrupt Treg suppressive function and how chemokines, like lymphotactin, enhance Treg suppressive function. We also study Treg function in tolerance. -
Helen Nadel
Clinical Professor, Radiology - Pediatric Radiology
Current Research and Scholarly Interests Clinical research and scholarly interests include topics in Pediatric Nuclear Medicine to include AI evaluation for scintigraphic quantitation, PET MR evaluation of optimized techniques for use in pediatric patient managment
-
Claude M. Nagamine, DVM, PhD
Associate Professor of Comparative Medicine at the Stanford University Medical Center
Current Research and Scholarly Interests Mouse models to study murine and human infectious diseases. These colloborative studies include dengue virus, zika virus, adeno-associated virus, coxsackie virus, enterovirus 71, enterohepatic helicobacters, campylobacters, and anaplasma.
-
Seema Nagpal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly Interests I'm a board certified neuro-oncologist who treats both primary brain tumors as well as metastatic disease to the brain and nervous system. My research concentrates on clinical trials for patients with late-stage central nervous system cancer. I have a special interest in leptomeningeal disease, a devastating complication of lung and breast cancers. I collaborate with Stanford scientists to detect this disease earlier, and with our breast and lung oncologists to improve outcomes for patients.
